"Andrew Edward Left is an activist short seller, author and editor of the online investment newsletter Citron Research, formerly StockLemon.com. Under the name Citron Research, Left publishes reports on firms that he claims are overvalued or are engaged in fraud. "
Yes, biotechs with potential coronavirus vaccines, diagnostics, and treatments are prone to wild swings, similar to public mood and panic around the coronavirus itself.